Annual Net Income
-$402.27 M
-$178.78 M-80.00%
31 December 2023
Summary:
Vaxcyte annual net profit is currently -$402.27 million, with the most recent change of -$178.78 million (-80.00%) on 31 December 2023. During the last 3 years, it has fallen by -$302.19 million (-301.96%). PCVX annual net income is now -1264.31% below its all-time high of -$29.48 million, reached on 31 December 2018.PCVX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$103.12 M
+$25.58 M+19.87%
30 September 2024
Summary:
Vaxcyte quarterly net profit is currently -$103.12 million, with the most recent change of +$25.58 million (+19.87%) on 30 September 2024. Over the past year, it has increased by +$77.68 million (+42.96%). PCVX quarterly net income is now -866.94% below its all-time high of -$10.66 million, reached on 30 June 2019.PCVX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$507.65 M
-$10.46 M-2.10%
30 September 2024
Summary:
Vaxcyte TTM net profit is currently -$507.65 million, with the most recent change of -$10.46 million (-2.10%) on 30 September 2024. Over the past year, it has dropped by -$105.38 million (-26.20%). PCVX TTM net income is now -3613.32% below its all-time high of -$13.67 million, reached on 31 March 2019.PCVX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +43.0% | -26.2% |
| 3 y3 years | -302.0% | -261.0% | -407.3% |
| 5 y5 years | -700.1% | -605.3% | -909.8% |
PCVX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -302.0% | at low | -261.0% | +43.0% | -407.3% | at low |
| 5 y | 5 years | -700.1% | at low | -605.3% | +43.0% | -909.8% | at low |
| alltime | all time | -1264.3% | at low | -866.9% | +43.0% | -3613.3% | at low |
Vaxcyte Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$103.12 M(-19.9%) | -$507.65 M(+2.1%) |
| June 2024 | - | -$128.70 M(+35.4%) | -$497.19 M(+13.8%) |
| Mar 2024 | - | -$95.02 M(-47.4%) | -$436.82 M(+8.6%) |
| Dec 2023 | -$402.27 M(+80.0%) | -$180.80 M(+95.1%) | -$402.27 M(+34.3%) |
| Sept 2023 | - | -$92.66 M(+35.6%) | -$299.51 M(+13.1%) |
| June 2023 | - | -$68.34 M(+13.0%) | -$264.77 M(+8.1%) |
| Mar 2023 | - | -$60.46 M(-22.5%) | -$244.96 M(+9.6%) |
| Dec 2022 | -$223.49 M(+123.3%) | -$78.05 M(+34.8%) | -$223.49 M(+28.4%) |
| Sept 2022 | - | -$57.92 M(+19.3%) | -$174.00 M(+21.9%) |
| June 2022 | - | -$48.53 M(+24.5%) | -$142.70 M(+21.1%) |
| Mar 2022 | - | -$38.99 M(+36.5%) | -$117.84 M(+17.8%) |
| Dec 2021 | -$100.08 M | -$28.56 M(+7.3%) | -$100.08 M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$26.61 M(+12.4%) | -$92.25 M(+6.5%) |
| June 2021 | - | -$23.68 M(+11.6%) | -$86.65 M(+4.0%) |
| Mar 2021 | - | -$21.22 M(+2.3%) | -$83.30 M(-6.6%) |
| Dec 2020 | -$89.22 M(+77.5%) | -$20.74 M(-1.3%) | -$89.22 M(+7.4%) |
| Sept 2020 | - | -$21.02 M(+3.4%) | -$83.10 M(+13.2%) |
| June 2020 | - | -$20.32 M(-25.1%) | -$73.40 M(+15.1%) |
| Mar 2020 | - | -$27.14 M(+85.6%) | -$63.74 M(+26.8%) |
| Dec 2019 | -$50.27 M(+70.5%) | -$14.62 M(+29.2%) | -$50.27 M(+41.0%) |
| Sept 2019 | - | -$11.32 M(+6.1%) | -$35.65 M(+46.5%) |
| June 2019 | - | -$10.66 M(-22.0%) | -$24.34 M(+78.0%) |
| Mar 2019 | - | -$13.67 M | -$13.67 M |
| Dec 2018 | -$29.48 M | - | - |
FAQ
- What is Vaxcyte annual net profit?
- What is the all time high annual net income for Vaxcyte?
- What is Vaxcyte quarterly net profit?
- What is the all time high quarterly net income for Vaxcyte?
- What is Vaxcyte quarterly net income year-on-year change?
- What is Vaxcyte TTM net profit?
- What is the all time high TTM net income for Vaxcyte?
- What is Vaxcyte TTM net income year-on-year change?
What is Vaxcyte annual net profit?
The current annual net income of PCVX is -$402.27 M
What is the all time high annual net income for Vaxcyte?
Vaxcyte all-time high annual net profit is -$29.48 M
What is Vaxcyte quarterly net profit?
The current quarterly net income of PCVX is -$103.12 M
What is the all time high quarterly net income for Vaxcyte?
Vaxcyte all-time high quarterly net profit is -$10.66 M
What is Vaxcyte quarterly net income year-on-year change?
Over the past year, PCVX quarterly net profit has changed by +$77.68 M (+42.96%)
What is Vaxcyte TTM net profit?
The current TTM net income of PCVX is -$507.65 M
What is the all time high TTM net income for Vaxcyte?
Vaxcyte all-time high TTM net profit is -$13.67 M
What is Vaxcyte TTM net income year-on-year change?
Over the past year, PCVX TTM net profit has changed by -$105.38 M (-26.20%)